X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs TTK HEALTHCARE - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS TTK HEALTHCARE J.B.CHEMICALS/
TTK HEALTHCARE
 
P/E (TTM) x 17.5 18.3 95.5% View Chart
P/BV x 2.4 6.0 39.8% View Chart
Dividend Yield % 0.2 0.5 33.5%  

Financials

 J.B.CHEMICALS   TTK HEALTHCARE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
TTK HEALTHCARE
Mar-14
J.B.CHEMICALS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs318663 47.9%   
Low Rs200399 50.0%   
Sales per share (Unadj.) Rs148.0535.6 27.6%  
Earnings per share (Unadj.) Rs19.115.9 119.7%  
Cash flow per share (Unadj.) Rs23.920.0 119.6%  
Dividends per share (Unadj.) Rs0.504.00 12.5%  
Dividend yield (eoy) %0.20.8 25.7%  
Book value per share (Unadj.) Rs128.9137.6 93.7%  
Shares outstanding (eoy) m84.827.77 1,091.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.0 176.3%   
Avg P/E ratio x13.633.3 40.7%  
P/CF ratio (eoy) x10.826.5 40.7%  
Price / Book Value ratio x2.03.9 52.0%  
Dividend payout %2.625.1 10.4%   
Avg Mkt Cap Rs m21,9514,127 531.8%   
No. of employees `0002.71.7 160.1%   
Total wages/salary Rs m1,841607 303.5%   
Avg. sales/employee Rs Th4,590.92,436.7 188.4%   
Avg. wages/employee Rs Th673.4355.2 189.6%   
Avg. net profit/employee Rs Th592.172.5 816.2%   
INCOME DATA
Net Sales Rs m12,5514,162 301.6%  
Other income Rs m54261 885.0%   
Total revenues Rs m13,0934,223 310.0%   
Gross profit Rs m2,055197 1,042.5%  
Depreciation Rs m41232 1,300.9%   
Interest Rs m9630 320.1%   
Profit before tax Rs m2,088197 1,061.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46973 644.4%   
Profit after tax Rs m1,619124 1,306.5%  
Gross profit margin %16.44.7 345.7%  
Effective tax rate %22.537.0 60.7%   
Net profit margin %12.93.0 433.2%  
BALANCE SHEET DATA
Current assets Rs m7,7781,629 477.5%   
Current liabilities Rs m4,3581,058 412.0%   
Net working cap to sales %27.213.7 198.6%  
Current ratio x1.81.5 115.9%  
Inventory Days Days5530 183.6%  
Debtors Days Days8034 238.2%  
Net fixed assets Rs m5,713556 1,026.9%   
Share capital Rs m17078 218.3%   
"Free" reserves Rs m10,547878 1,200.8%   
Net worth Rs m10,9371,069 1,022.8%   
Long term debt Rs m0159 0.0%   
Total assets Rs m15,5742,399 649.1%  
Interest coverage x22.87.6 301.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.81.7 46.5%   
Return on assets %11.06.4 171.7%  
Return on equity %14.811.6 127.7%  
Return on capital %20.018.5 108.2%  
Exports to sales %48.70.8 6,162.9%   
Imports to sales %7.11.4 505.4%   
Exports (fob) Rs m6,11533 18,586.3%   
Imports (cif) Rs m88958 1,524.4%   
Fx inflow Rs m6,16933 18,750.8%   
Fx outflow Rs m1,28563 2,033.7%   
Net fx Rs m4,884-30 -16,123.7%   
CASH FLOW
From Operations Rs m1,397127 1,103.2%  
From Investments Rs m-320-146 219.4%  
From Financial Activity Rs m-1,19622 -5,460.3%  
Net Cashflow Rs m-1023 -4,092.0%  

Share Holding

Indian Promoters % 55.4 65.4 84.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 3.7 91.6%  
FIIs % 3.9 5.2 75.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 25.8 143.4%  
Shareholders   30,437 12,723 239.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FRESENIUS KABI ONCO.  STERLING BIOTECH  ASTRAZENECA PHARMA  SUN PHARMA  IPCA LABS  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Retail Inflation, Growth in India's Aviation Sector, and Top Cues in Focus Today(Pre-Open)

Share markets in India witnessed buying interest during closing hours yesterday and ended the day on a positive note.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Nov 13, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - AUROBINDO PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS